INFANTILE FIBROSARCOMA
Clinical trials for INFANTILE FIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new INFANTILE FIBROSARCOMA trials appear
Sign up with your email to follow new studies for INFANTILE FIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults up to age 30 who have certain cancers (solid tumors or leukemia) with a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control the cancer. About 33 particip…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New pill shows promise against rare childhood cancers
Disease control OngoingThis study tests an oral drug called LOXO 292 in 36 children with advanced solid or brain tumors that have a specific genetic change (RET alteration). The goal is to see if the drug can shrink tumors and control the disease. Participants must have already tried standard treatment…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 19, 2026 11:49 UTC